United States· US:28595-802_0e764061-e7a9-6701-e063-6394a90a489f
HISTEX
A triprolidine product containing triprolidine hydrochloride, registered in United States by Allegis Pharmaceuticals, LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Triprolidine is registered in 3 of 19 countries.
Countries holding a registration under ATC R06AX07 (triprolidine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Triprolidine · ATC R06AX07
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIPROLIDINE HYDROCHLORIDE
- Manufacturer
- Allegis Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- R06AX07
- ATC class
- Triprolidine
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc112859580208237 mL in 1 BOTTLE (28595-802-08)
- ndc1128595-802-08
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
313 interactions on record for triprolidine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triprolidine · interactions on record
313 records
- 9 severe
- 302 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triprolidine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8f23f8b-6d4f-48fe-9d2a-eab532c31263 GET /v1/drugs/b8f23f8b-6d4f-48fe-9d2a-eab532c31263?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5",
"substance": "TRIPROLIDINE HYDROCHLORIDE",
"productndc": "28595-802",
"dosage_form": "SYRUP",
"dea_schedule": null,
"strength_unit": "mg/5mL",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about triprolidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.